Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shanghai Green Valley Pharmaceuticals
Pharma
Enhertu, ADC trial deaths, Takeda—Fierce Pharma Asia
Enhertu enters first-line treatment. Daiichi paused an ADC trial following patient deaths. Takeda touts a pair of positive TYK2 readouts. Plus more.
Angus Liu
Dec 19, 2025 8:00am
Fosun looks to revive Green Valley's embattled Alzheimer's med
Dec 16, 2025 1:36am
China did not renew approval of controversial Alzheimer's drug
Aug 14, 2025 11:22am
Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia
May 20, 2022 9:15am
Trial for controversial China-made Alzheimer's drug aborted
May 13, 2022 4:16pm
Biogen, Pfizer, Lilly and more win China NRDL coverage
Dec 3, 2021 10:15am
